A Clinical Trial to Test the Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis

Trial Profile

A Clinical Trial to Test the Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs Squaric acid dibutylester (Primary)
  • Indications Herpes labialis
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 May 2017 New trial record
    • 14 May 2017 Results published in the Journal of American Medical Association Dermatology (JAMA Dermatology) in May 2017, according to a Squarex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top